Biotechnology
GYRE
11.54
price down icon8.12%   -1.02
after-market Dopo l'orario di chiusura: 11.55 0.01 +0.09%

Gyre Therapeutics Inc (GYRE)
full-star
loading
Panoramica Notizia Cronologia dei prezzi Perché GYRE Giù? Forum Previsione
Precedente Chiudi:
$12.56
Aprire:
$12.52
Volume 24 ore:
63,575
Relative Volume:
0.63
Capitalizzazione di mercato:
$990.39M
Reddito:
$106.66M
Utile/perdita netta:
$15.16M
Rapporto P/E:
123.42
EPS:
0.0935
Flusso di cassa netto:
$6.37M
1 W Prestazione:
-3.67%
1M Prestazione:
+5.29%
6M Prestazione:
-3.51%
1 anno Prestazione:
-18.33%
Intervallo 1D:
Value
$11.54
$12.73
Intervallo di 1 settimana:
Value
$11.54
$12.80
Portata 52W:
Value
$8.26
$26.37

Gyre Therapeutics Inc Stock (GYRE) Company Profile

Name
Nome
Gyre Therapeutics Inc
Name
Settore
Healthcare (1169)
Name
Industria
Biotechnology (678)
Name
Telefono
(619) 949-3681
Name
Indirizzo
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Name
Dipendente
391
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
GYRE's Discussions on Twitter

Confronta GYRE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GYRE
Gyre Therapeutics Inc
 11.54 990.39M 106.66M 15.16M 6.37M 0.0935
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
 644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
 120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-04-29 Ripresa Stephens Overweight
2021-02-10 Iniziato Piper Sandler Overweight
2020-05-21 Iniziato Raymond James Outperform
2019-01-04 Iniziato Oppenheimer Outperform
2018-02-12 Reiterato B. Riley FBR, Inc. Buy
2018-02-09 Reiterato Chardan Capital Markets Buy
2017-12-08 Iniziato B. Riley FBR, Inc. Buy
2017-06-12 Iniziato Chardan Capital Markets Buy
2017-06-06 Iniziato Ladenburg Thalmann Buy
2016-06-30 Iniziato Rodman & Renshaw Buy
Mostra tutto

Gyre Therapeutics Inc Borsa (GYRE) Ultime notizie

pulisher
03:01 AM

Gyre Therapeutics president Ma Songjiang sells $49,380 in stock By Investing.com - Investing.com Australia

03:01 AM
pulisher
Feb 21, 2025

Gyre Therapeutics president Ma Songjiang sells $49,380 in stock - Investing.com

Feb 21, 2025
pulisher
Feb 18, 2025

Gyre Therapeutics Faces Revenue Decline Amidst Future Prospects - TipRanks

Feb 18, 2025
pulisher
Feb 16, 2025

Gyre therapeutics president Ma Songjiang sells $46,360 in stock - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Gyre therapeutics president Ma Songjiang sells $45,434 in stock - MSN

Feb 15, 2025
pulisher
Feb 14, 2025

Gyre therapeutics president Ma Songjiang sells $46,360 in stock By Investing.com - Investing.com Nigeria

Feb 14, 2025
pulisher
Feb 13, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Songjiang Ma Sells 2,000 Shares - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

Gyre Therapeutics president sells $45,380 in stock - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Gyre therapeutics president Ma Songjiang sells $45,434 in stock By Investing.com - Investing.com Nigeria

Feb 13, 2025
pulisher
Feb 11, 2025

Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 By Investing.com - Investing.com Australia

Feb 11, 2025
pulisher
Feb 11, 2025

Gyre Therapeutics president Ma Songjiang sells shares totaling $50,020 - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat

Feb 11, 2025
pulisher
Feb 08, 2025

Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - Armenian Reporter

Feb 08, 2025
pulisher
Feb 07, 2025

Gyre therapeutics president Ma Songjiang sells $48,029 in stock - MSN

Feb 07, 2025
pulisher
Feb 06, 2025

Gyre therapeutics president Ma Songjiang sells $48,029 in stock By Investing.com - Investing.com Canada

Feb 06, 2025
pulisher
Feb 05, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 14.4% in January - MarketBeat

Feb 05, 2025
pulisher
Feb 02, 2025

Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $22,360.00 in Stock - MarketBeat

Feb 02, 2025
pulisher
Jan 30, 2025

Gyre Therapeutics president sells $45,380 in stock By Investing.com - Investing.com Australia

Jan 30, 2025
pulisher
Jan 29, 2025

Gyre Therapeutics president Ma Songjiang sells $42,760 in stock - MSN

Jan 29, 2025
pulisher
Jan 27, 2025

Gyre Therapeutics president Ma Songjiang sells $42,760 in stock By Investing.com - Investing.com Australia

Jan 27, 2025
pulisher
Jan 24, 2025

Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 By Investing.com - Investing.com Nigeria

Jan 24, 2025
pulisher
Jan 24, 2025

Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 - MSN

Jan 24, 2025
pulisher
Jan 24, 2025

Barclays PLC Has $116,000 Stock Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World

Jan 24, 2025

Gyre Therapeutics Inc Azioni (GYRE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Simile a GYRE

biotechnology RPRX
$33.42
price up icon 0.27%
biotechnology INSM
$81.06
price down icon 3.05%
biotechnology UTHR
$361.10
price down icon 1.70%
biotechnology SMMT
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
biotechnology BNTX
$120.01
price up icon 1.81%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):